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• Increased body fat, obesity, and prediabetes are all 
linked to increased risk of cancers in 
postmenopausal women
• Excess fat can create inflammatory environment -
> tumor cell invasion and proliferation1
• Visceral fat in particular is known to cause adipose 
tissue dysfunctionality leading to inflammation2
• Adiponectin (APN) is a protein with anti-
inflammatory, antiproliferative, and proapoptotic 
properties
• decreased in women with obesity
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Methods
Secondary analysis of baseline data from 26 
postmenopausal women with obesity (body 
mass index >30) from a randomized biomarker 
study of metformin and lifestyle intervention.4
• Adiponectin was measured using routine 
clinical testing procedures after a fasting 
blood draw
• Visceral fat area was estimated from Dual 
Energy X-Ray Absorptiometry Scan (Hologic 
Discovery W QDR DXA system,Waltham, MA).
• Approximated subcutaneous fat mass by 
subtracting visceral fat mass from total fat 
mass 
Data analysis:
Correlation test: to test associations between 
adiponectin and subcutaneous fat and visceral 
fat
Multiple Regression: to determine if 
subcutaneous fat and visceral fat can predict 
adiponectin levels when controlling for 
participant body mass index
Research Question
Results
Scatter Plot showing Correlation between Adiponectin Levels 
and Subcutaneous Fat Mass
Scatter Plot showing Correlation between Adiponectin 
Levels and Visceral Fat Area
Results Continued
Circulating level of APN is inversely correlated 
with obesity, but… can it be correlated with 
specific types of fat?
Objective: determine whether visceral fat (around 
the internal organs and along the muscle wall) or 
subcutaneous fat (just beneath the skin) are 
correlated with APN levels
Tables Detailing Results from Multiple Regression Controlling 
for Participant BMI
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• Visceral fat area and subcutaneous fat mass cannot be used to 
predict APN levels in post-menopausal women who are obese and 
have pre-diabetes
• Neither the correlation between APN and visceral fat nor the 
correlation between APN and subcutaneous fat is significant
Limitations of the data available:
- Subcutaneous fat mass is an estimation and includes intramuscular 
fat
- Data doesn’t include full range of BMI (obese women only) and 
thus association between adiposity and APN may be reduced
- Limited sample size
Future Directions:
- More investigation is needed to determine if there is a connection 
between visceral fat or subcutaneous fat and APN
- Consider using data with larger sample size to account for smaller 
range and thus, try for statistically significant results
Relation to Cancer Prevention:
- Further investigation into they type of fat associated with 
biomarkers of cancer risk such as APN can direct interventions in 
high risk people, potentially increasing the effectiveness of these 
interventions
Correlation to APN Significance
Visceral Fat (n=25) -.178 .395
Subcutaneous Fat (n=25) .098 .640
Binary Correlation of Visceral and Subcutaneous Fat 
with Adiponectin
Responsible Research Conduct: All data was deidentified, and data was requested through proper channels
Neither correlation is significant, but visceral fat is weakly negatively 
correlated with APN while subcutaneous fat is not correlated with 
APN.
N %
Race (Black/White/Other) 12 / 15 / 2 41.1 / 51.7 / 6.8
Ethnicity (Hispanic/Non-Hispanic) 5 / 24 17.2 / 82.8
Demographics of Study Participants
Background
Model R R Square Adjusted R 
Square
Std. Error of 
the Estimate
F Value Significance 
(P Value)
1 .072a .005 -.038 4.996 .119 .773a
2 .353b .125 .000 4.904 .998 .413b
a. Predictors: (Constant), BODY_MASS_INDEX.1
b. Predictors: (Constant), BODY_MASS_INDEX.1, VFAT_AREA.1, SUBQFAT_MASS.1.
Model Summary
Multiple Regression does not give statistically significant prediction of 
APN levels. None of the variables on their own are statistically significant.
